Samples from 916 members of various ethnic groups from malaria-endemic southern Shan State, Myanmar, were analyzed for ␣-thalassemia (␣-thal), ␤-thalassemia (␤-thal), abnormal hemoglobin variants, and glucose-6-phosphate dehydrogenase (G6PD) deficiency. Of these subjects, 530 (57.9%) were found to have at least one of these red cell genetic disorders. The overall frequencies for the various red cell genetic disorders were as follows: ␣-thal, 37.5% (343/916); hemoglobin E (Hb-E), 20.3% (186/916); G6PD-Mahidol, 17.5% (160/916); and ␤-thal, 0.3% (3/916). The frequencies of combined disorders were 6.9% (63/ 916) for ␣-thal/Hb-E, 5.7% (52/916) for ␣-thal/G6PD-Mahidol, 2.8% (26/916) for Hb-E/G6PD-Mahidol, 1.1% (10/916) for ␣-thal/Hb-E/G6PD-Mahidol, and 0.1% (1/916) for ␣-thal/␤-thal/G6PD-Mahidol. Of the various ethnic and non-ethnic groups, the Bamar population showed the highest frequencies of ␣-thal (56.9%, 177/311), Hb-E (28.3%, 88/311), and G6PD-Mahidol (21.2%, 66/311) (all duplicated and triplicated cases were included). In addition, 2 new mutations, an ␣ gene triplication (/␣␣␣ anti3.7 ; 0.2%, 2/916) and Hb-Neapolis (0.1%, 1/916), were detected. Our results showed that race was the dominant factor affecting the frequencies of red cell genetic disorders in malaria-endemic areas of Myanmar.
Introduction
Hemoglobinopathies, thalassemias, and glucose-6-phosphate dehydrogenase (G6PD) deficiency are red cell genetic disorders that are widespread in various parts of the world, including Africa, the Mediterranean region, and Asia.The geographical distribution of these disorders is closely related to the past and present distribution of malaria because of a selective advantage against malarial infection that is conferred to heterozygotes [1] . The regions of Myanmar in which malaria is endemic show some of the highest known frequencies of thalassemia, hemoglobin E (Hb-E), and G6PD deficiency. The country's overall frequencies of ␣-thalassemia (␣-thal), ␤-thalassemia (␤-thal), and Hb-E have been reported as 5% to 15%, 0.5% to 5%, and 1% to 26%, respectively [2] . A population-based study that screened for G6PD deficiency reported that 91.3% (73/80) of G6PD variants in various ethnic populations of Myanmar were G6PD-Mahidol [3, 4] . In this study, we established the frequencies of ␣-thal, ␤-thal, Hb-E, and G6PD deficiency in various ethnic and non-ethnic groups among the population living in malarial areas.
Materials and Methods

Area Background and Study Population
Shan State is a mountainous region in the eastern sector of Myanmar. It is bordered by China to the north, China and Laos to the east, and Thailand to the south. It is divided into 3 parts, northern Shan State, southern Shan State, and eastern Shan State. Shan State has a tropical climate with 3 seasons. In the winter season (November to February), the minimum temperature is 12ЊC. In the summer season (March to 
Sample Collection
Peripheral blood (2 mL) was collected in a tube containing disodium EDTA as an anticoagulant and was kept frozen after separation into red cells and plasma. Blood was collected only after informed consent had been obtained.
DNA Extraction
Genomic DNA was extracted from red cells with a QIAamp kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. The extracted DNA was kept at 4ЊC.
Hemoglobin Typing
The concentrations of Hb-A, Hb-A 2 , Hb-F, and any Hb variants were assessed by high-performance liquid chromatography (HPLC) (Tosoh Corporation, Tokyo, Japan). The carrier state for ␤-thal was diagnosed for samples in which the concentration of Hb-A 2 exceeded 3.5%. We could confirm this diagnosis for most samples by directly identifying the ␤-thal mutations in the extracted DNA. Samples with a borderline concentration of Hb-A 2 , that is, in the range of 3% to 3.5%, were also examined in this way. Similarly, the bulk of the Hb-E mutations identified by HPLC analysis were confirmed by isoelectric focusing, DNA diagnosis, and Mnl I restriction enzyme analysis.
Identification of Red Cell Genetic Mutations
For characterizing the genotypes and finding the underlying mutations, we used the amplification refractory mutation system (ARMS), a method based on the polymerase chain reaction (PCR). 10] . PCR amplification was performed directly without screening for G6PD deficiency by using primers 487-F and 487-R for G6PD-Mahidol and primers 871-F and 871-R for G6PD-Viangchan. The products were identified after digesting with Hind III and Xba I restriction enzymes [11, 12] . All oligonucleotides are listed in Table 2 .
Results
The prevalences of ␣-thal, ␤-thal, abnormal Hb variants, and G6PD deficiency among the 916 subjects belonging to various ethnic and non-ethnic groups in the 4 villages of southern Shan State in Myanmar are shown in Table 3 . Of these subjects, 57.9% (530/916) had at least one of the examined red cell genetic disorders (Table 1 ). The overall number of red cell genetic disorders was 693 among the 916 people examined (Table 3) .
The overall frequency of ␣-globin gene mutations was 37.5% (343/916) ( Table 3) . ␣-Thal-2 (-␣ 3.7 /␣␣) and ␣-thal-1 (-␣ 3.7 /-␣ 3.7 ) were the 2 most common genotypes. Heterozygous ␣-thal-2 was present in 79.3% (272/343) of individuals with ␣-globin gene mutations, and homozygous ␣-thal-1 was present in 14% (48/343). Fifteen of 343 ␣-thal carriers (4.3%; higher frequencies in the Pa-O and Shan groups) exhibited the loss of both linked ␣-globin genes as the --SEA type, and
